Markus Muttenthaler Selected Research

Markus Muttenthaler Research Topics

3	Neoplasms (Cancer) 01/2024 - 01/2020
3	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2020
2	Neoplasm Metastasis (Metastasis) 07/2022 - 01/2020
2	Mental Disorders (Mental Disorder) 01/2022 - 11/2016
2	Abdominal Pain (Pain, Abdominal) 01/2021 - 01/2014
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2021 - 08/2020
1	Cancer Pain 02/2024
1	Nervous System Diseases (Neurological Disorders) 02/2024
1	Pain (Aches) 12/2023
1	Carcinogenesis 07/2022
1	Triple Negative Breast Neoplasms 07/2022
1	Disease Progression 07/2022
1	Autism Spectrum Disorder 01/2022
1	Schizophrenia (Dementia Praecox) 01/2022
1	Ulcerative Colitis 10/2021
1	Diarrhea 10/2021
1	Dysbiosis 10/2021
1	Constipation 01/2021
1	Multiple Sclerosis 01/2021
1	Osteoporosis 01/2021
1	HIV Infections (HIV Infection) 01/2021
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2021
1	Chronic Pain 01/2021
1	Hypersensitivity (Allergy) 01/2014

5	Oxytocin (Pitocin)FDA LinkGeneric 02/2024 - 01/2014
4	Peptides (Polypeptides)IBA 01/2024 - 08/2020
4	Oxytocin Receptors (Oxytocin Receptor)IBA 01/2024 - 01/2014
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 07/2022 - 11/2016
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 07/2022
2	NeuropeptidesIBA 01/2022 - 01/2020
1	Vasopressins (Vasopressin)IBA 02/2024
1	Epidermal Growth Factor (EGF)IBA 07/2022
1	Bile Acids and Salts (Bile Acids)IBA 10/2021
1	linaclotideIBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	LigandsIBA 11/2016
1	Analgesics (Analgesic Drugs)IBA 01/2014